top of page Shop the GLP-1 Products Collection the GLP-1 Newsroom Blog & News Page GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets
Developed by Novo Nordisk, this long-acting amylin analogue works by activating amylin receptors throughout the body, particularly in areas that regulate appetite and digestive function [1]
More patients receiving semaglutide discontinued because of GI symptoms, including nausea, diarrhoea and vomiting.
The impact of weekly semaglutide, a glucagon-like peptide-1 agonist, on kidney outcomes in adults with type 2 diabetes mellitus